ACS Survey: Trends and Needs in Early Drug Discovery Outsourcing

In an effort to explore trends and needs in early drug discovery outsourcing, Dotmatics commissioned the ACS to survey biotechs and CROs who are collaborating on early small molecule drug discovery projects.

Survey Summary

An online survey was made available via email invitation to Chemical and Engineering News readers who selfidentified as working in small molecule drug discovery. It was launched in January 2023 and was available for nearly six weeks. Two-hundred-seventy-eight individuals submitted responses. Key demographics of respondents are summarized in the references.

The survey engaged both biotech/biopharma/pharma companies (“bio companies”) who outsource to service providers, as well as service providers themselves. It asked numerous questions regarding categories of companies engaged, types of projects undertaken, technology solutions employed, data formats and processes used, solution and technology gaps, etcetera.